Page 54 - CBAC Newsletter 2016

Publications

July 2015 - July 2016

douglas l. mann, M.D. (Con't.)

Capetanaki Y. Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8
and K18. Nat Med. 2015 Sep;21(9):1076-84. doi: 10.1038/nm.3925. Epub 2015 Aug 17. PMID: 26280121
Anker SD, Coats AJ, Cristian G, Dragomir D, Pusineri E, Piredda M, Bettari L, Dowling R, Volterrani M, Kirwan BA,
Filippatos G, Mas JL, Danchin N, Solomon SD, Lee RJ, Ahmann F, Hinson A, Sabbah HN, Mann DL. A
prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on
functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial).
Eur Heart J. 2015 Sep 7;36(34):2297-309. doi: 10.1093/eurheartj/ehv259. Epub 2015 Jun 16.
PMID: 26082085, PMCID:PMC4561351
Lindman BR, Tong CW, Carlson DE, Balke CW, Jackson EA, Madhur MS, Barac A, Abdalla M, Brittain EL, Desai N,
Kates AM, Freeman AM, Mann DL. National Institutes of Health Career Development Awards for
Cardiovascular Physician-Scientists: Recent Trends and Strategies for Success. J Am Coll Cardiol.
2015 Oct 20;66(16):1816-27. PMID: 26483107, PMCID: PMC4615587
Freudenberger RS, Cheng B, Mann DL, Thompson JL, Sacco RL, Buchsbaum R, Sanford A, Pullicino PM, Levin B,
Teerlink JR, Graham S, Mohr JP, Labovitz AJ, Di Tullio MR, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD,
Homma S; WARCEF Investigators. The first prognostic model for stroke and death in patients with systolic
heart failure. J Cardiol. 2015 Nov 5. pii: S0914-5087(15)00309-3. [Epub ahead of print]. PMID: 26549533
Mann DL, Lee RJ, Coats AJ, Neagoe G, Dragomir D, Pusineri E, Piredda M, Bettari L, Kirwan BA, Dowling R, Volterrani
M, Solomon SD, Sabbah HN, Hinson A, Anker SD. One-year follow-up results from AUGMENT-HF: a multicentre
randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment
of heart failure. Eur J Heart Fail. 2016 Mar;18(3):314-25. Epub 2015 Nov 11. PMID: 26555602
Hartupee J, Mann DL. Role of inflammatory cells in fibroblast activation. J Mol Cell Cardiol. 2016 Apr;93:143-8.
Epub 2015 Nov 20. Review. PMID: 26593723, PMCID: PMC4846511
Zipes DP, Neuzil P, Theres H, Caraway D, Mann DL, Mannheimer C, Van Buren P, Linde C, Linderoth B, Kueffer F,
Sarazin SA, DeJongste MJ; DEFEAT-HF Trial Investigators. Determining the Feasibility of Spinal Cord
Neuromodulation for the Treatment of Chronic Systolic Heart Failure: The DEFEAT-HF Study. JACC Heart Fail.
2016 Feb;4(2):129-36. Epub 2015 Dec 9. PMID: 26682789
Carney RM, Freedland KE, Steinmeyer B, Rubin EH, Mann DL, Rich MW.Cardiac Risk Markers and Response to
Depression Treatment in Patients With Coronary Heart Disease. Psychosom Med. 2016 Jan;78(1):49-59.
PMID: 26452173, PMCID: PMC4696885
Kato TS, Di Tullio MR, Qian M, Wu M, Thompson JL, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR,
Graham S, Lip GY, Levin B, Mohr JP, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S; WARCEF
Investigators. Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart
Failure - Subanalysis of the WARCEF Trial. Circ J. 2016;80(3):619-26. Epub 2016 Jan 22. PMID: 26804607
Topkara VK, Chambers KT, Yang KC, Tzeng HP, Evans S, Weinheimer C, Kovacs A, Robbins J, Barger P, Mann DL.
Functional significance of the discordance between transcriptional profile and left ventricular
structure/function during reverse remodeling. JCI Insight. 2016 Apr 6;1(4):e86038. PMID: 27158672,
PMCID: PMC4855517
Byku M, Mann DL. Neuromodulation of the failing heart: Lost in translation? JACC Basic Transl Sci.
2016 Apr;1(3):95-106. PMID:2752317, PMCID: PMC4978351
Gurvitz M, Burns KM, Brindis R, Broberg CS, Daniels CJ, Fuller SM, Honein MA, Khairy P, Kuehl KS, Landzberg MJ,
Mahle WT, Mann DL, Marelli A, Newburger JW, Pearson GD, Starling RC, Tringali GR, Valente AM, Wu JC,

50 | CBAC Center Heartbeat